Use of rituximab in pediatric patients with steroidresistant nephrotic syndrome. A single center study

Introduction: Steroids are the cornerstone of therapy for nephrotic syndrome (NS) with a remission rate as high as 90%. In patients who do not respond to them or are steroid dependent, other immunosuppressive drugs have been used. Although rituximab use in NS is off-label, many authors have publishe...

Full description